Related Experiment Video

Updated: Jan 19, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.3K

Breast cancer

Nadia Harbeck1, Frédérique Penault-Llorca2, Javier Cortes3,4

  • 1LMU Munich, University Hospital, Department of Obstetrics and Gynecology, Breast Center and Comprehensive Cancer Center (CCLMU), Munich, Germany. nadia.harbeck@med.uni-muenchen.de.

Nature Reviews. Disease Primers
|September 25, 2019
PubMed

Insights

Breast cancer is a heterogeneous disease with varying treatability based on stage and molecular subtype. Advances include targeted therapies and immunotherapy, but global access to these innovations remains a challenge.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer is the most common female malignancy, with early stages being curable but advanced, metastatic disease remaining incurable.
  • The disease is molecularly heterogeneous, characterized by subtypes such as HER2-activated, hormone receptor-positive, and BRCA-mutated.
  • Current management involves a multidisciplinary approach combining locoregional treatments and diverse systemic therapies.

Purpose of the Study:

  • To provide an overview of the current understanding and treatment landscape of breast cancer.
  • To highlight the importance of molecular subtyping in guiding treatment strategies.
  • To discuss emerging therapeutic concepts and future challenges in breast cancer care.

Main Methods:

  • Review of current literature on breast cancer epidemiology, molecular classification, and treatment modalities.
  • Analysis of systemic therapies including endocrine therapy, chemotherapy, anti-HER2 therapy, and immunotherapy.
  • Discussion of future directions in personalized medicine and treatment de-escalation/escalation.

Main Results:

  • Treatment strategies are tailored to specific molecular subtypes of breast cancer.
  • A range of systemic therapies are available, including endocrine therapy, chemotherapy, anti-HER2 agents, PARP inhibitors, and immunotherapy.
  • Individualization of therapy based on tumor biology and early response is a key future concept.

Conclusions:

  • Breast cancer management requires a multidisciplinary approach tailored to molecular subtypes.
  • Ongoing research is driving innovations in systemic therapies, including immunotherapy.
  • Ensuring equitable global access to advanced breast cancer treatments is a critical future challenge.

More Related Videos

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

842
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.8K

Related Concept Videos

What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.0K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.9K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.5K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.7K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650